Literature DB >> 15463319

Diagnosis of Chagas disease using recombinant DNA technology.

A C Frasch1, M B Reyes.   

Abstract

In this article, Alberto Frasch and Maria Reyes discuss the development of new tools for the serodiagnosis of Chagas disease (caused by Trypanosoma cruzi) and describe recombinant antigens that have proved to be of great diagnostic potential in distinguishing different stages of the disease. The work is important because different treatment strategies are needed for acute and chronic infection.

Entities:  

Year:  1990        PMID： 15463319     DOI： 10.1016/0169-4758(90)90234-u

Source DB:  PubMed          Journal:  Parasitol Today        ISSN： 0169-4758


  10 in total

1.  Comparison of recombinant Trypanosoma cruzi peptide mixtures versus multiepitope chimeric proteins as sensitizing antigens for immunodiagnosis.

Authors:  Cecilia Camussone; Verónica Gonzalez; María S Belluzo; Nazarena Pujato; María E Ribone; Claudia M Lagier; Iván S Marcipar
Journal:  Clin Vaccine Immunol       Date:  2009-04-01

2.  PCR-based detection of Trypanosoma cruzi useful for specific diagnosis of human Chagas' disease.

Authors: 
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

3.  Utility of recombinant flagellar calcium-binding protein for serodiagnosis of Trypanosoma cruzi infection.

Authors:  L M Godsel; R S Tibbetts; C L Olson; B M Chaudoir; D M Engman
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

4.  The major cysteine proteinase (cruzipain) from Trypanosoma cruzi is antigenic in human infections.

Authors:  J Martinez; O Campetella; A C Frasch; J J Cazzulo
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

5.  Identification and synthesis of a major conserved antigenic epitope of Trypanosoma cruzi.

Authors:  J M Burns; W G Shreffler; D E Rosman; P R Sleath; C J March; S G Reed
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

6.  Assay for detection of Trypanosoma cruzi antibodies in human sera based on reaction with synthetic peptides.

Authors:  U Vergara; M Lorca; C Veloso; A Gonzalez; A Engstrom; L Aslund; U Pettersson; A C Frasch
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

7.  Identification and detection of Trypanosoma cruzi by using a DNA amplification fingerprint obtained from the ribosomal intergenic spacer.

Authors:  N González; I Galindo; P Guevara; E Novak; J V Scorza; N Añez; J F Da Silveira; J L Ramírez
Journal:  J Clin Microbiol       Date:  1994-01       Impact factor: 5.948

Review 8.  Chagas' disease.

Authors:  H B Tanowitz; L V Kirchhoff; D Simon; S A Morris; L M Weiss; M Wittner
Journal:  Clin Microbiol Rev       Date:  1992-10       Impact factor: 26.132

9.  Early diagnosis of congenital Trypanosoma cruzi infection, using shed acute phase antigen, in Ushuaia, Tierra del Fuego, Argentina.

Authors:  María Cristina Mallimaci; Sergio Sosa-Estani; Graciela Russomando; Zunilda Sanchez; Carina Sijvarger; Isabel Marcela Alvarez; Lola Barrionuevo; Carlos Lopez; Elsa Leonor Segura
Journal:  Am J Trop Med Hyg       Date:  2010-01       Impact factor: 2.345

10.  Identification of the gene(s) coding for the trans-sialidase of Trypanosoma cruzi.

Authors:  A J Parodi; G D Pollevick; M Mautner; A Buschiazzo; D O Sanchez; A C Frasch
Journal:  EMBO J       Date:  1992-05       Impact factor: 11.598
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.